Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults.
Christopher Wildeman, a leading scholar on mass incarceration and child maltreatment, will become director of the Bronfenbrenner Center for Translational Research as of July 1.
A year into Cornell’s Academic Integration Initiative, Gary Koretzky ’78 is relocating to Ithaca and taking on a new title to continue leading efforts to better promote, build and enhance collaborative research efforts across Cornell's campuses.
Recognition of the link between human and animal abuse has helped spur a slowly growing system for investigating and prosecuting crimes against animals. Cornell veterinary pathologists play a key role, performing necropsies and delivering expert testimony.
Dynamic Boundaries, a startup that aims to relieve pain and improve mobility for patients suffering from severe osteoarthritis, joined Cornell’s McGovern Center, a business incubator, June 1.
A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis.
